Beijing Tong Ren Tang Chinese Medicine Company Limited (TQR.F)
| Previous close | 1.1900 |
| Open | 1.1500 |
| Bid | 1.1300 x 780000 |
| Ask | 1.2200 x 780000 |
| Day's range | 1.1500 - 1.1500 |
| 52-week range | 1.0300 - 1.8700 |
| Volume | |
| Avg. volume | 70 |
| Market cap | 972.547M |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 14.38 |
| EPS (TTM) | 0.0800 |
| Earnings date | 14 Mar 2024 |
| Forward dividend & yield | 0.04 (3.24%) |
| Ex-dividend date | 04 June 2024 |
| 1y target est | N/A |
Simply Wall St.Three High Yield Dividend Stocks In Hong Kong Offering Up To 8.4%
Amid a generally positive backdrop in global markets, with indices like the Hang Seng showing notable gains, investors are increasingly attentive to opportunities within Hong Kong's dividend stock arena. In this context, understanding the characteristics that define a robust dividend stock is crucial, especially in a market buoyed by recovery optimism and solid holiday spending figures.
- Reuters
UPDATE 1-Chinese listed firms used endangered animal parts as ingredients -report
Three listed Chinese drugmakers, whose investors include or use some of the world's biggest banks, used parts of endangered animals as ingredients in their products, an environmental group said in a report published Monday. The London-based Environmental Investigation Agency (EIA) urged investors in Beijing Tong Ren Tang group, Tianjin Pharmaceutical group and Jilin Aodong Pharmaceutical Group to divest their stakes. Beijing Tong Ren Tang and Tianjin Pharmaceutical group did not respond to Reuters' emails or calls seeking comment.
- Reuters
Three listed Chinese firms used endangered animal parts as ingredients- report
Three publicly traded Chinese drugmakers which count global banks such as UBS and HSBC as investors have used parts of endangered animals as ingredients in their products, an environmental group said. In a report published Monday, the London-based Environmental Investigation Agency urged global investors in the three firms - Beijing Tong Ren Tang group, Tianjin Pharmaceutical group and Jilin Aodong Pharmaceutical Group - to divest their stakes. The three companies are among a list of 72 firms the environmental non-profit organisation (NGO) said used body parts of threatened leopards and pangolins as ingredients in at least 88 traditional Chinese medicine (TCM) products.
